Toggle light / dark theme

How Data Is Critical to Engineering Antibodies to Block COVID-19

Posted in bioengineering, biotech/medical

Shahrad Daraeikia, Jack Wang, and Dr. Jean-Philippe Buerckert sit down together with Harry Glorikian at MoneyBall Medicine to talk about our ultra rapid antibody discovery race to a cure for COVID19.


Episode Summary

Distributed Bio aims to use its computational antibody engineering platform to identify antibodies that protect against SARS and optimize them to block the SARS-CoV2 coronavirus. This week Harry gets a progress update from three key Distributed Bioscientists.

We also have an unedited video of the episode below.

Leave a Reply